U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Jim Gaffigan has struggled with his weight for most of his adult life, but it seems that his most recent 50-lb weight loss is ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...